AstraZeneca PLC ADR (AZN): Price and Financial Metrics

AZN POWR Grades

• Sentiment is the dimension where AZN ranks best; there it ranks ahead of 93.37% of US stocks.
• The strongest trend for AZN is in Stability, which has been heading up over the past 177 days.
• AZN ranks lowest in Momentum; there it ranks in the 7th percentile.

AZN Stock Summary

• AZN has a market capitalization of $210,493,840,075 -- more than approximately 99.27% of US stocks.
• With a price/earnings ratio of 64.02, ASTRAZENECA PLC P/E ratio is greater than that of about 91.66% of stocks in our set with positive earnings.
• In terms of twelve month growth in earnings before interest and taxes, ASTRAZENECA PLC is reporting a growth rate of 272.29%; that's higher than 94.53% of US stocks.
• Stocks that are quantitatively similar to AZN, based on their financial statements, market capitalization, and price volatility, are PFE, CSCO, NVS, BABA, and ADBE.
• Visit AZN's SEC page to see the company's official filings. To visit the company's web site, go to www.astrazeneca.com.

AZN Valuation Summary

• AZN's EV/EBIT ratio is 60.8; this is 821.21% higher than that of the median Healthcare stock.
• Over the past 243 months, AZN's price/earnings ratio has gone up 42.7.

Below are key valuation metrics over time for AZN.

AZN Growth Metrics

Its 3 year price growth rate is now at 74.78%.
• Its 3 year cash and equivalents growth rate is now at 39.31%.
• The 2 year cash and equivalents growth rate now stands at 68.83%.

Over the past 70 months, AZN's revenue has gone up $22,059,000,000.

The table below shows AZN's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-12-31	44,351	9,808	3,288
2022-12-31	44,351	9,808	3,288
2022-09-30	45,154	8,828	2,039
2022-06-30	44,038	7,617	-1,253
2022-03-31	41,487	7,261	-1,063
2021-12-31	37,417	5,963	112

AZN's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• AZN has a Quality Grade of B, ranking ahead of 78.56% of graded US stocks.
• AZN's asset turnover comes in at 0.438 -- ranking 104th of 681 Pharmaceutical Products stocks.
• CLVS, HSKA, and FLXN are the stocks whose asset turnover ratios are most correlated with AZN.

The table below shows AZN's key quality metrics over time.